TY - JOUR
T1 - The human high-risk plaque and its detection by magnetic resonance imaging
AU - Fayad, Zahi A.
AU - Fuster, Valentin
N1 - Funding Information:
Supported in part by grants from the Radiological Society of North America; the New York Community Trust; the National Heart, Lung, and Blood Institute-National Institutes of Health (Nos. P50-HL-54469, R01-HL-61801, R01-HL-61814); Merck & Company, Inc; Magna Laboratories; General Electric Medical Systems; and by funds from the Cardiovascular Institute and the Department of Radiology of the Mount Sinai School of Medicine.
PY - 2001/7/19
Y1 - 2001/7/19
N2 - The study of atherosclerotic disease during its natural history and after therapeutic intervention will enhance our understanding of the progression and regression of this disease and will aid in selecting the appropriate treatments. Several invasive and noninvasive imaging techniques are available to assess vessels in atherosclerotic disease. Most of the standard techniques, however, identify luminal diameter or stenosis, wall thickness, or plaque volume. None of the standard techniques can characterize the composition of an atherosclerotic plaque and therefore are incapable of identifying the high-risk plaques. High-resolution, multicontrast, magnetic resonance imaging (MRI) can noninvasively image vulnerable plaques and characterize plaques in terms of their different components (ie, lipid, fibrous, calcium, or thrombus). Application of MRI opens up whole new areas for diagnosis, prevention, and treatment of atherosclerosis.
AB - The study of atherosclerotic disease during its natural history and after therapeutic intervention will enhance our understanding of the progression and regression of this disease and will aid in selecting the appropriate treatments. Several invasive and noninvasive imaging techniques are available to assess vessels in atherosclerotic disease. Most of the standard techniques, however, identify luminal diameter or stenosis, wall thickness, or plaque volume. None of the standard techniques can characterize the composition of an atherosclerotic plaque and therefore are incapable of identifying the high-risk plaques. High-resolution, multicontrast, magnetic resonance imaging (MRI) can noninvasively image vulnerable plaques and characterize plaques in terms of their different components (ie, lipid, fibrous, calcium, or thrombus). Application of MRI opens up whole new areas for diagnosis, prevention, and treatment of atherosclerosis.
UR - https://www.scopus.com/pages/publications/0035913092
U2 - 10.1016/S0002-9149(01)01769-6
DO - 10.1016/S0002-9149(01)01769-6
M3 - Article
C2 - 11473746
AN - SCOPUS:0035913092
SN - 0002-9149
VL - 88
SP - 42
EP - 45
JO - American Journal of Cardiology
JF - American Journal of Cardiology
IS - 2 SUPPL. 1
ER -